FHS Researchers Develop Multi-Biomarker Panel to Predict Risk of Chronic Kidney Disease | GenomeWeb

By Adam Bonislawski

A study examining more than 2,300 participants from the National Heart, Lung, and Blood Institute's Framingham Heart Study has identified three serum biomarkers that improve risk prediction for chronic kidney disease and microalbuminuria.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.